Stay informed with the latest litigation news. Explore now

IP Verse

Amylin Pharmaceuticals, Inc. patent opposition analysis

Get complete Patent Opposition Report for Amylin Pharmaceuticals, Inc.

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Latest patents of Amylin Pharmaceuticals, Inc. opposed by its competitors

Explore Amylin Pharmaceuticals, Inc.'s recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 18, 2025

Patent Number	Grant Date	Title	Total Oppositions
EP2341905	Sep 13, 2023	Sustained Release Formulations Using Non-Aqueous Carriers	1
EP2347762	May 8, 2019	Exendin For Treating Diabetes And Reducing Body Weight	2

Top competitors of Amylin Pharmaceuticals, Inc.

INSTONE

GENERICS UK